CVE-2026-80144
Command injection
- Published22 Sept 2026
Description
Lantronix SLC8000/SLC9000 before firmware v9.7.0.2, EMG8500/EMG7500 before firmware v9.7.0.1, and all firmware versions of SLB882/SLCx-03/SLCx-02 contain a command injection vulnerability that allows authenticated attackers to execute arbitrary shell commands as root by exploiting an undocumented mfc eeprom write command that passes unsanitized user input to a system() call. Attackers can authenticate as any user to the terminal or CLI interface and inject malicious commands through the unsanitized parameter to achieve complete loss of confidentiality, integrity, and availability on the affected device and potentially impact downstream serial-attached devices.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:HRemediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
- https://revrb.net/2026/09/21/revrb-lantern.html
- https://ts.lantronix.com/ftp/emg/EMG_7500/9.7.0.1R2/
- https://ts.lantronix.com/ftp/emg/EMG_8500/9.7.0.1R2/
- https://ts.lantronix.com/ftp/slc8000/9.7.0.2R1/
- https://ts.lantronix.com/ftp/SLC9000/9.7.0.2R1/
- https://www.vulncheck.com/advisories/lantronix-autonomous-out-of-band-devices-cli-command-injection-via-mfc-eeprom-write
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2026-80144 being actively exploited?
CVE-2026-80144 is not in the CISA KEV catalog. Its EPSS exploit probability is 1.51%.
How severe is CVE-2026-80144?
CVE-2026-80144 has a CVSS 3.1 base score of 9.9, rated critical. EPSS estimates a 1.51% probability of exploitation.
How do I fix CVE-2026-80144?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2026-80144 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.